相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PGE2-induced colon cancer growth is mediated by mTORC1
Marc Dufour et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients
Isabel Sicking et al.
BMC CANCER (2014)
Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties
Namita Kundu et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
An EP4 Antagonist ONO-AE3-208 Suppresses Cell Invasion, Migration, and Metastasis of Prostate Cancer
Song Xu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
Y-box binding protein 1-A prognostic marker and target in tumour therapy
Corinna Kosnopfel et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2014)
A Randomized, Placebo-Controlled, Multicenter, Biomarker-Selected, Phase 2 Study of Apricoxib in Combination with Erlotinib in Patients with Advanced Non-Small-Cell Lung Cancer
Barbara J. Gitlitz et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
Prostaglandin E2 stimulates β1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-κB pathway
Xiaoming Bai et al.
SCIENTIFIC REPORTS (2014)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: CATALYTIC RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: NUCLEAR HORMONE RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ENZYMES
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: G PROTEIN-COUPLED RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
TGF-β Effects on Prostate Cancer Cell Migration and Invasion Are Mediated by PGE2 through Activation of PI3K/AKT/mTOR Pathway
BaoHan T. Vo et al.
ENDOCRINOLOGY (2013)
Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy
Yifang Han et al.
EUROPEAN JOURNAL OF CANCER (2013)
5 Immune system: a double-edged sword in cancer
Bodduluru Lakshmi Narendra et al.
INFLAMMATION RESEARCH (2013)
Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer
Grace O'Callaghan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The Multiple Faces of Prostaglandin E2 G-Protein Coupled Receptor Signaling during the Dendritic Cell Life Cycle
Sandra De Keijzer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells
Man-Tat Lau et al.
CANCER LETTERS (2012)
Prostaglandin E2 and T cells: friends or foes?
Vinatha Sreeramkumar et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Role of dendritic cells in progression and clinical outcome of colon cancer
Maya V. Gulubova et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2012)
Regulation of Immune Responses by Prostaglandin E-2
Pawel Kalinski
JOURNAL OF IMMUNOLOGY (2012)
Modulation of Host Natural Killer Cell Functions in Breast Cancer via Prostaglandin E2 Receptors EP2 and EP4
Dawn M. Holt et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model
Xiping Xin et al.
LABORATORY INVESTIGATION (2012)
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation
Dianren Xia et al.
NATURE MEDICINE (2012)
COX-2 Inhibitors and Cardiovascular Risk
Christopher P. Cannon et al.
SCIENCE (2012)
Generation of myeloid-derived suppressor cells using prostaglandin E-2
Natasa Obermajer et al.
TRANSPLANTATION RESEARCH (2012)
In vitro and in vivo characterization of PF-044189948, a novel, potent and selective prostaglandin EP2 receptor antagonist
K. J. af Forselles et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
At last, a truly selective EP2 receptor antagonist
Mark A. Birrell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The role of the EP receptors for prostaglandin E2 in skin and skin cancer
J. E. Rundhaug et al.
CANCER AND METASTASIS REVIEWS (2011)
ANGPTL4 Induction by Prostaglandin E2 under Hypoxic Conditions Promotes Colorectal Cancer Progression
Sun-Hee Kim et al.
CANCER RESEARCH (2011)
Activation of epidermal growth factor receptor signaling by the prostaglandin E2 receptor EP4 pathway during gastric tumorigenesis
Hiroko Oshima et al.
CANCER SCIENCE (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Nuclear Orphan Receptor NR4A2 Modulates Fatty Acid Oxidation Pathways in Colorectal Cancer
Vijaykumar R. Holla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
D. F. Woodward et al.
PHARMACOLOGICAL REVIEWS (2011)
Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations
Jill Wykosky et al.
Chinese Journal of Cancer (2011)
PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling
Ludovic Martinet et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis
Hidefumi Kubo et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: An update on the molecular mechanisms
William Ka Kei Wu et al.
CANCER LETTERS (2010)
PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis
Maozhen Tian et al.
FASEB JOURNAL (2010)
Prostaglandin E2/EP1 Signaling Pathway Enhances Intercellular Adhesion Molecule 1 (ICAM-1) Expression and Cell Motility in Oral Cancer Cells
Shun-Fa Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Prostaglandin E Receptor EP1 Suppresses Breast Cancer Metastasis and Is Linked to Survival Differences and Cancer Disparities
Xinrong Ma et al.
MOLECULAR CANCER RESEARCH (2010)
Bone marrow-derived EP3-expressing stromal cells enhance tumor-associated angiogenesis and tumor growth
Yasuhumi Ogawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis
Hideki Amano et al.
CANCER SCIENCE (2009)
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Andrew T. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Fas Signal Promotes Lung Cancer Growth by Recruiting Myeloid-Derived Suppressor Cells via Cancer Cell-Derived PGE2
Yongliang Zhang et al.
JOURNAL OF IMMUNOLOGY (2009)
Prostaglandin E-2-EP4 signaling promotes immune inflammation through T(H)1 cell differentiation and T(H)17 cell expansion
Chengcan Yao et al.
NATURE MEDICINE (2009)
Human EP3I prostanoid receptor induces VEGF and VEGF receptor-1 mRNA expression
Tomoko Taniguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells
G. O'Callaghan et al.
BRITISH JOURNAL OF CANCER (2008)
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer
Shalini Jain et al.
CANCER RESEARCH (2008)
Prostanoid receptor EP1 expression in breast cancer
Mangesh A. Thorat et al.
MODERN PATHOLOGY (2008)
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: A cohort study
Roopali Bansal Gupta et al.
GASTROENTEROLOGY (2007)
EP1-4 subtype, COX and PPARγ receptor expression in colorectal cancer in prediction of disease-specific mortality
Annika Gustafsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells
Pratima Sinha et al.
CANCER RESEARCH (2007)
Prostaglandin E receptors
Yukihiko Sugimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A prostaglandin E-2 receptor subtype EP1-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis
Hiroki Makita et al.
CARCINOGENESIS (2007)
EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival
M. Kamiyama et al.
ONCOGENE (2006)
Prostaglandin E2 receptor distribution and function in the gastrointestinal tract
I. Dey et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism
Li Yang et al.
CANCER RESEARCH (2006)
Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia
Abderrahmane Kaidi et al.
CANCER RESEARCH (2006)
Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis
XR Ma et al.
CANCER RESEARCH (2006)
Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence
SD Chell et al.
CANCER RESEARCH (2006)
Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer
VR Holla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Role of β-arrestin 1 in the metastatic progression of colorectal cancer
FG Buchanan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Epidermal growth factor receptor (EGFR) signaling in cancer
N Normanno et al.
GENE (2006)
Importance of the EP1 receptor in cutaneous UVB-induced inflammation and tumor development
Kathleen L. Tober et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis
Y Shoji et al.
CARCINOGENESIS (2005)
Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development
YM Sung et al.
CANCER RESEARCH (2005)
Differential expression of E prostanoid receptors in murine and human non-melanoma skin cancer
JL Lee et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: A phase II trial of celecoxib and docetaxel
I Csiki et al.
CLINICAL CANCER RESEARCH (2005)
Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+CD25+ T regulatory cell activities in lung cancer
S Sharma et al.
CANCER RESEARCH (2005)
The prostaglandin R2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia
SH Chang et al.
CANCER RESEARCH (2005)
Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist
N Niho et al.
CANCER SCIENCE (2005)
Regulation of vascular endothelial cell growth factor expression in mouse mammary tumor cells by the EP2 subtype of the prostaglandin E2 receptor
SH Chang et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2005)
Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression
SH Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development
Y Shoji et al.
GUT (2004)
Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3′,5′-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways
KJ Sales et al.
MOLECULAR ENDOCRINOLOGY (2004)
Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice
T Kitamura et al.
CANCER SCIENCE (2003)
Epidermal growth factor receptor: mechanisms of activation and signalling
RN Jorissen et al.
EXPERIMENTAL CELL RESEARCH (2003)
Host prostaglandin E2-EP3 signaling regulates tumor-associated angiogenesis and tumor growth
H Amano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer
PM Siegel et al.
NATURE REVIEWS CANCER (2003)
Prostaglandin catabolizing enzymes
HH Tai et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma
O Gallo et al.
HUMAN PATHOLOGY (2002)
Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2
H Fujino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Prostaglandin E-2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy
R Pai et al.
NATURE MEDICINE (2002)
Prostaglandins as modulators of immunity
SG Harris et al.
TRENDS IN IMMUNOLOGY (2002)
Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development
T Kawamori et al.
CARCINOGENESIS (2001)
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
M Sonoshita et al.
NATURE MEDICINE (2001)
Inhibitory effect of a prostaglandin E receptor subtype EP1 selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice
K Watanabe et al.
CANCER LETTERS (2000)
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs
M Abramovitz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
分享论文
